Literature DB >> 176926

Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.

M Finland, C Garner, C Wilcox, L D Sabath.   

Abstract

Tests for susceptibility of 29 group A, 4 group C, and 2 group G strains of beta-hemolytic streptococci to 63 antibiotics and to trimethoprim and sulfamethoxazole, singly and combined in a ratio of 1:16, were carried out in vitro. All strains tested were moderately or highly susceptible to all the antibiotics used except those belonging to the aminoglycoside and polymyxin groups. A few were also resistant to the tetracyclines and to sulfamethoxazole alone. Comparisons with results obtained in previous years indicate that, except for the tetracyclines and sulfonamides, there has been no change in the susceptibility of beta-hemolytic streptococci to the most important and useful antibiotics, particularly penicillin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176926      PMCID: PMC429467          DOI: 10.1128/AAC.9.1.11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Ampicillin activity in vitro and absorption and excretion in normal young men.

Authors:  J O KLEIN; M FINLAND
Journal:  Am J Med Sci       Date:  1963-05       Impact factor: 2.378

2.  Antibotics in the treatment of betahemolytic streptococcal pharyngitis: factors influencing the results.

Authors:  M STILLERMAN; S H BERNSTEIN; M L SMITH; S B GITTELSON; S KARELITZ
Journal:  Pediatrics       Date:  1960-01       Impact factor: 7.124

3.  An outbreak of pharyngitis due to tetracyclineresistant group A, type 12 streptococci.

Authors:  W J MOGABGAB; W PELON
Journal:  AMA J Dis Child       Date:  1958-12

4.  In vitro activity of various penicillins.

Authors:  C G MCCARTHY; G WALLMARK; M FINLAND
Journal:  Am J Med Sci       Date:  1961-02       Impact factor: 2.378

5.  Tetracycline resistance of group A beta hemolytic streptococci.

Authors:  H A KUHARIC; C E ROBERTS; W M KIR BY
Journal:  JAMA       Date:  1960-12-03       Impact factor: 56.272

6.  Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.

Authors:  W F JONES; H A FELDMAN; M FINLAND
Journal:  Am J Clin Pathol       Date:  1957-02       Impact factor: 2.493

7.  Susceptibility of enterococci and of hemolytic streptococci of groups A, B, C, and G to five new antibiotics in vitro.

Authors:  W F JONES; M FINLAND
Journal:  Am J Clin Pathol       Date:  1957-05       Impact factor: 2.493

8.  Medical organization in national catastrophe.

Authors:  M A CASBERG
Journal:  J Am Med Assoc       Date:  1954-02-06

9.  The antibacterial action of erythromycin.

Authors:  T H HAIGHT; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1952-10

10.  Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.

Authors:  J E McGowan; M W Barnes; M Finland
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

View more
  13 in total

1.  How many antibiotics.

Authors: 
Journal:  Br Med J       Date:  1976-09-25

2.  Throat swab culture & sensitivity reports - an overview.

Authors:  P T Wakode; S H Gawarle; S V Joshi; R Bajoriya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2003-04

3.  Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase.

Authors:  G Swedberg; S Ringertz; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Authors:  Asha C Bowen; Rachael A Lilliebridge; Steven Y C Tong; Robert W Baird; Peter Ward; Malcolm I McDonald; Bart J Currie; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

6.  Heterogeneity of tetracycline resistance determinants in Streptococcus.

Authors:  V Burdett; J Inamine; S Rajagopalan
Journal:  J Bacteriol       Date:  1982-03       Impact factor: 3.490

7.  Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.

Authors:  Y Miyamoto; K Takizawa; A Matsushima; Y Asai; S Nakatsuka
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 9.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

Review 10.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.